This fund invests in a portfolio of 20 international healthcare giants. They include such widely recognized names as Johnson & Johnson, Merck, Pfizer, and Bristol-Myers Squibb as well as some companies you may not be familiar with like Quest Diagnostics and Anthem.
Income Investor
The fund has traded in a narrow range between $8.18 and $9.47 over the past year. It’s close to the bottom end of that range. Monthly distributions are US$0.06, or $0.72 a year. Assuming that rate continues, the forward yield is 8.7%. The U units have never lost money over a calendar year since they were launched in 2017. The average annual compound rate of return since inception is 9.2%. - Gordon Pape
Sorry!
Only current subscribers of The Income Investor may view the details of this recommendation.
Interactive Performance Chart
HHL.U was first recommended here on July 2, 2018